Sulzer Medica
This article was originally published in The Gray Sheet
Executive Summary
Former parent firm Sulzer Ltd. initiates arbitration proceedings against the orthopedics firm seeking to "confirm legal validity and executability of Sulzer Medica's obligation to indemnify Sulzer Ltd." against device-related expenses and damage claims, Sulzer Ltd. says Dec. 20. "Over the past few weeks Sulzer Medica has...repeatedly denied any obligation to indemnify," Sulzer Ltd. claims. Sulzer Medica is seeking to settle claims related to its Inter-Op hip recall and Natural Knee II implant withdrawals via a proposed $783 mil. settlement (1"The Gray Sheet" Dec. 3, 2001, p. 20)...
You may also be interested in...
Sulzer Medica Optimistic That Mediation Agreement Will Prevent Bankruptcy
An agreement attempting to resolve the suit between Sulzer Orthopedics and injured parties through a third party signals a recognition by plaintiffs that the litigation could bankrupt parent Sulzer Medica, according to the Winterhur, Switzerland company
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.